Stacie Bell, Ph.D.
Chief Scientific and Medical Officer
Stacie Bell, Ph.D., joined the National Psoriasis Foundation in 2018 and serves as the Chief Scientific and Medical Officer. She is responsible for providing vision, leadership and overall management of NPF’s research and medical programs and is the foundation representative on the NPF Medical Board and Scientific Advisory Committee. Dr. Bell also oversees the NPF COVID-19 Task Force. She directs the research activities of the organization, including the development and implementation of policies and programs and grants/fellowship funding that support the NPF strategic plan and research objectives. She is also responsible for overseeing educational programming and outreach activities for medical professionals serving patients with psoriatic disease. Dr. Bell is passionate about collaboration and integrating research and scientific considerations into all the pillars of the Foundation’s work in pursuit of the organizational mission including advocacy and access to care.
Dr. Bell came to NPF with 25 years of diverse experience in drug, biologic and medical device research, education, program strategy and product development. Prior to joining NPF, she served in a number of leadership roles in biotechnology and pharma. Dr. Bell has been a therapeutic area representative for her organizations. She has been involved with most phases and functional lines of the pre-clinical research and clinical development process, including time with medical affairs in several therapeutic areas, including immunology, rheumatology, dermatology, infectious disease and has worked extensively with the FDA. Through the years, Dr. Bell has also consulted for late stage discovery and early clinical development programs. She received her doctorate in biochemistry from Vanderbilt University and a Bachelor of Science degree in chemistry from the University of North Dakota. Dr. Bell also has secondary training in Clinical Pharmacology and Research.